Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Lymphoma; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse Phase 2 ClinicalTrials
CONTENTS